Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bokemeyer

Showing results (31-40 of 333) with videos related to

Pageof 34
Sort By:
The New England Journal of Medicine|March 24, 1994
Clinical implications of the p53 tumor-suppressor geneC Bokemeyer, M A Kuczyk, J Sehrt
Drugs|September 3, 1999
Diagnosis and treatment of patients with testicular germ cell cancerJ T Hartmann, L Kanz, C Bokemeyer
European Journal of Clinical Investigation|November 12, 2005
Anaemia in cancer patients: pathophysiology, incidence and treatmentC Bokemeyer, K Oechsle, J-T Hartmann
Praxis|December 31, 1997
[Current aspects of adjuvant and palliative chemotherapy in colorectal carcinoma]C Bokemeyer, J T Hartmann, L Kanz
Onkologie|March 10, 2004
Elderly patients with acute myeloid leukaemia: characteristics in biology, patients and treatment. Recommendations of the Working Group Geriatric Oncology of the German Society for Haematology and Oncology (DGHO), the Austrian Society for Haematology and Oncology (OGHO) and the German Society for Geriatrics (DGG)U Wedding, C Bokemeyer, J G Meran, et al.
World Journal of Urology|April 2, 2004
Advances in our understanding of the biology, new diagnostic approaches and recent treatment strategies for testicular germ cell cancerM Kuczyk, C Bokemeyer, J T Hartmann
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Side-effects of GM-CSF treatment in advanced testicular cancerC Bokemeyer, H J Schmoll, A Harstrick
Hamostaseologie|January 10, 2009
[Haemostatic aspects in clinical oncology]F Langer, K Holstein, B Eifrig, et al.
Onkologie|July 7, 2001
[Chemotherapy of colorectal cancer--which therapy is justified for elderly patients?]F Honecker, U Wedding, G Kolb, et al.
Der Internist|October 13, 2010
[A multi-disciplinary approach to the treatment of germ cell tumors]F Honecker, R Souchon, S Krege, et al.
Pageof 34

Showing results (31-40 of 333) with videos related to

Sort By:
Pageof 34
The New England Journal of Medicine|March 24, 1994
Clinical implications of the p53 tumor-suppressor geneC Bokemeyer, M A Kuczyk, J Sehrt
Drugs|September 3, 1999
Diagnosis and treatment of patients with testicular germ cell cancerJ T Hartmann, L Kanz, C Bokemeyer
European Journal of Clinical Investigation|November 12, 2005
Anaemia in cancer patients: pathophysiology, incidence and treatmentC Bokemeyer, K Oechsle, J-T Hartmann
Praxis|December 31, 1997
[Current aspects of adjuvant and palliative chemotherapy in colorectal carcinoma]C Bokemeyer, J T Hartmann, L Kanz
Onkologie|March 10, 2004
Elderly patients with acute myeloid leukaemia: characteristics in biology, patients and treatment. Recommendations of the Working Group Geriatric Oncology of the German Society for Haematology and Oncology (DGHO), the Austrian Society for Haematology and Oncology (OGHO) and the German Society for Geriatrics (DGG)U Wedding, C Bokemeyer, J G Meran, et al.
World Journal of Urology|April 2, 2004
Advances in our understanding of the biology, new diagnostic approaches and recent treatment strategies for testicular germ cell cancerM Kuczyk, C Bokemeyer, J T Hartmann
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Side-effects of GM-CSF treatment in advanced testicular cancerC Bokemeyer, H J Schmoll, A Harstrick
Hamostaseologie|January 10, 2009
[Haemostatic aspects in clinical oncology]F Langer, K Holstein, B Eifrig, et al.
Onkologie|July 7, 2001
[Chemotherapy of colorectal cancer--which therapy is justified for elderly patients?]F Honecker, U Wedding, G Kolb, et al.
Der Internist|October 13, 2010
[A multi-disciplinary approach to the treatment of germ cell tumors]F Honecker, R Souchon, S Krege, et al.
Pageof 34